HEDS Ref Set App: El-Serag (2024)
- Abbreviated Name
- HEDS Ref Set App: El-Serag (2024)
- Lead Investigator
- El-Serag, Hashem — Baylor College of Medicine
- Coordinating Investigator
- Zheng, Yingye — Fred Hutchinson Cancer Center
- Involved Investigators
Abstract
External Validation of HES V2.0 and Comparison with GALAD for Detection of Hepatocellular Carcinoma (HCC). A Phase 3 Biomarker Study in the United States
Aims
External Validation of HES V2.0 and Comparison with GALAD for Detection of Hepatocellular Carcinoma (HCC). A Phase 3 Biomarker Study in the United States
Analytic Method
Analyzed by DMCC
Outcome
External Validation of HES V2.0 and Comparison with GALAD for Detection of Hepatocellular Carcinoma (HCC). A Phase 3 Biomarker Study in the United States
Publications
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
Team Project
- Start Date
- Mar 1 2024
- Finish Date
- Jun 1 2026
- Protocol ID
- 546
- Protocol Type
- Reference Set
- Fields of Research
-
- Glycomics
- Proteomics
- Collaborative Group
- G.I. and Other Associated Cancers Research Group
- Cancer Types
-
- Liver cell carcinoma